Correlation Between Johnson Johnson and Theriva Biologics
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Theriva Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Theriva Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Theriva Biologics, you can compare the effects of market volatilities on Johnson Johnson and Theriva Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Theriva Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Theriva Biologics.
Diversification Opportunities for Johnson Johnson and Theriva Biologics
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Johnson and Theriva is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Theriva Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Theriva Biologics and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Theriva Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Theriva Biologics has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Theriva Biologics go up and down completely randomly.
Pair Corralation between Johnson Johnson and Theriva Biologics
Considering the 90-day investment horizon Johnson Johnson is expected to generate 0.12 times more return on investment than Theriva Biologics. However, Johnson Johnson is 8.22 times less risky than Theriva Biologics. It trades about -0.01 of its potential returns per unit of risk. Theriva Biologics is currently generating about -0.06 per unit of risk. If you would invest 16,351 in Johnson Johnson on August 26, 2024 and sell it today you would lose (834.00) from holding Johnson Johnson or give up 5.1% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Johnson Johnson vs. Theriva Biologics
Performance |
| Timeline |
| Johnson Johnson |
| Theriva Biologics |
Johnson Johnson and Theriva Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Johnson Johnson and Theriva Biologics
The main advantage of trading using opposite Johnson Johnson and Theriva Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Theriva Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theriva Biologics will offset losses from the drop in Theriva Biologics' long position.| Johnson Johnson vs. Capricor Therapeutics | Johnson Johnson vs. Akari Therapeutics PLC | Johnson Johnson vs. Soleno Therapeutics | Johnson Johnson vs. Bio Path Holdings |
| Theriva Biologics vs. Eliem Therapeutics | Theriva Biologics vs. HCW Biologics | Theriva Biologics vs. Scpharmaceuticals | Theriva Biologics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |